Omniscient Neurotechnology secured a 36 million dollar Series D, led by the National Reconstruction...
The AMW Read
The article updates the player map for the AI-Bio/Healthcare segment with a Series D funding event for Omniscient Neurotechnology, though the round size ($36M) does not trigger the cross.§D threshold.
NoveltySignificance
Healthcare & Bio · Player Map
Omniscient Neurotechnology secured a 36 million dollar Series D, led by the National Reconstruction Fund, to scale its AI connectomics platform. The FDA-approved Quicktome system decodes brain networks from MRI scans, giving surgeons personalized maps to preserve cognitive function. This 20 million dollar NRF investment accelerates precision medicine while creating 40 specialized jobs. It marks AI's evolution from a diagnostic aid to an essential, reimburseable surgical tool. 🧠📊